OncoveryCare Welcomes Dr. Catherine Alfano to Enhance Survivorship Care
Company - People | Jul 21, 2025 | .406 Ventures Management LP
OncoveryCare, a company specializing in the delivery of virtual, comprehensive care for cancer survivors, has announced the appointment of Dr. Catherine M. Alfano as their new Chief Product & Strategy Officer. Dr. Alfano is expected to lead OncoveryCare in enhancing its offerings, focusing on holistic care solutions designed for the needs of cancer survivors. The company is part of .406 Ventures' portfolio, which underpins its commitment to investing in innovative healthcare solutions.
Sectors
- Healthcare
- Venture Capital
Geography
- United States – Both .406 Ventures and OncoveryCare are based in the United States, as implied by the context.
Industry
- Healthcare – The article focuses on OncoveryCare, a company providing healthcare solutions for cancer survivors.
- Venture Capital – .406 Ventures is a venture capital firm investing in OncoveryCare, demonstrating involvement in funding and supporting innovative companies in the healthcare sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| OncoveryCare | Target company | Company | Provides virtual, whole-person care to cancer survivors. |
| Dr. Catherine M. Alfano | Chief Product & Strategy Officer | Person | Newly appointed executive at OncoveryCare, tasked with leading product and strategy to improve survivorship care. |
| .406 Ventures Management LP | Investor | Company | A venture capital firm invested in OncoveryCare. |